rs6738645 was considered as significantly related to CAD across the four treatment cohorts (RNF181: meta-analysis hazard ratio = 1.26, p = 3.03E−105, FDR = 1.13E−73). This evidence concerns the gene RNF181 and coronary artery disorder.